期刊中文名:國際(ji)藥學(xue)實踐雜志ISSN:0961-7671E-ISSN:2042-7174
該雜志(zhi)國(guo)(guo)際(ji)(ji)簡稱:INT J PHARM PRACT,是(shi)由(you)出版商Oxford University Press出版的一本(ben)(ben)致力(li)于發(fa)(fa)(fa)布--研究新(xin)成(cheng)果的的專業學(xue)術期刊。主(zhu)要發(fa)(fa)(fa)表刊登有(you)創見的學(xue)術論文文章、行業最新(xin)科研成(cheng)果,扼要報道(dao)階段(duan)性(xing)研究成(cheng)果和(he)重要研究工作(zuo)的最新(xin)進展,選載對學(xue)科發(fa)(fa)(fa)展起(qi)指(zhi)導(dao)作(zuo)用的綜述(shu)與專論,促(cu)進學(xue)術發(fa)(fa)(fa)展,為廣大讀者服務。該刊是(shi)一本(ben)(ben)國(guo)(guo)際(ji)(ji)優秀雜志(zhi),在國(guo)(guo)際(ji)(ji)上有(you)很高的學(xue)術影響力(li)。
《International Journal Of Pharmacy Practice》是一(yi)本(ben)以English為(wei)主(zhu)的(de)(de)(de)(de)未開放(fang)獲取(qu)國(guo)(guo)際優秀期刊(kan),中文名稱(cheng)國(guo)(guo)際藥學實踐雜志,本(ben)刊(kan)主(zhu)要出(chu)版、報道領(ling)域(yu)的(de)(de)(de)(de)研(yan)究動(dong)(dong)態以及在該(gai)(gai)領(ling)域(yu)取(qu)得(de)的(de)(de)(de)(de)各方面的(de)(de)(de)(de)經(jing)驗和(he)科研(yan)成果(guo),介紹該(gai)(gai)領(ling)域(yu)有關(guan)本(ben)專(zhuan)業的(de)(de)(de)(de)最新進展(zhan),探(tan)討行業發展(zhan)的(de)(de)(de)(de)思路和(he)方法(fa),以促(cu)進學術(shu)信息交流,提高(gao)行業發展(zhan)。該(gai)(gai)刊(kan)已被國(guo)(guo)際權威數據庫SCIE收錄,為(wei)該(gai)(gai)領(ling)域(yu)相(xiang)關(guan)學科的(de)(de)(de)(de)發展(zhan)起到(dao)了良好的(de)(de)(de)(de)推動(dong)(dong)作用,也得(de)到(dao)了本(ben)專(zhuan)業人員(yuan)的(de)(de)(de)(de)廣泛認可(ke)。該(gai)(gai)刊(kan)最新影響因子為(wei)1.5,最新CiteScore 指(zhi)數為(wei)2.9。
The International Journal of Pharmacy Practice focuses on various aspects of pharmaceutical practice, providing a platform for pharmaceutical professionals worldwide to share their research findings, experiences, and perspectives, thereby promoting the development and improvement of pharmaceutical practice. The goal of the magazine is to publish high-quality original research articles, reviews, case reports, and short communications covering a wide range of pharmaceutical practices, including drug therapy management, drug policies and regulations, drug information and education, drug supply chain management, drug safety and quality, drug use evaluation, and drug economics. The main readership of this journal is pharmaceutical professionals, including pharmacists, pharmaceutical students, pharmaceutical educators, and researchers. Through the latest research findings and practical experience, this journal aims to help these readers improve their professional knowledge and skills in order to better serve patients and society.
按JIF指(zhi)標學(xue)科分區 |
學科:PHARMACOLOGY & PHARMACY
收錄子集:ESCI
分區:Q3
排名:265 / 354
百分位:
25.3% |
按(an)JCI指標學科分(fen)區 |
學科:PHARMACOLOGY & PHARMACY
收錄子集:ESCI
分區:Q4
排名:273 / 354
百分位:
23.02% |
JCR分區:JCR分(fen)(fen)區(qu)來自(zi)科(ke)(ke)睿唯安公司,JCR是一個獨特(te)的(de)(de)多學科(ke)(ke)期(qi)(qi)刊(kan)評(ping)價(jia)工(gong)具(ju),為唯一提(ti)供(gong)基于引文數據(ju)的(de)(de)統(tong)計信息(xi)的(de)(de)期(qi)(qi)刊(kan)評(ping)價(jia)資(zi)源(yuan)。每(mei)年發布的(de)(de)JCR分(fen)(fen)區(qu),設置了254個具(ju)體(ti)學科(ke)(ke)。JCR分(fen)(fen)區(qu)根據(ju)每(mei)個學科(ke)(ke)分(fen)(fen)類(lei)按照期(qi)(qi)刊(kan)當年的(de)(de)影響因(yin)子高(gao)低(di)將期(qi)(qi)刊(kan)平均(jun)分(fen)(fen)為4個區(qu),分(fen)(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)(fen)區(qu)中(zhong)期(qi)(qi)刊(kan)的(de)(de)數量是均(jun)勻(yun)分(fen)(fen)為四個部分(fen)(fen)的(de)(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Health Professions 小類:Pharmacy | Q2 | 12 / 45 |
74% |
大類:Health Professions 小類:Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | Q2 | 12 / 43 |
73% |
大類:Health Professions 小類:Health Policy | Q2 | 155 / 310 |
50% |
大類:Health Professions 小類:Public Health, Environmental and Occupational Health | Q3 | 339 / 665 |
49% |
大類:Health Professions 小類:Pharmaceutical Science | Q3 | 96 / 183 |
47% |
大類:Health Professions 小類:Pharmacology (medical) | Q3 | 157 / 272 |
42% |
該雜志是一本國際優秀雜志,在國際上有較(jiao)高(gao)(gao)(gao)的學(xue)術影(ying)響力,行業關注(zhu)度很(hen)高(gao)(gao)(gao),已被國際權(quan)威數據(ju)庫SCIE收錄,該雜志在綜合專業領域專業度認可很(hen)高(gao)(gao)(gao),對稿(gao)件內容的創新性和學(xue)術性要(yao)求很(hen)高(gao)(gao)(gao),作(zuo)為一本國際優秀雜志,一般投(tou)(tou)稿(gao)過審時(shi)(shi)間(jian)(jian)都(dou)較(jiao)長,投(tou)(tou)稿(gao)過審時(shi)(shi)間(jian)(jian)平(ping)均 ,如果想投(tou)(tou)稿(gao)該刊要(yao)做好時(shi)(shi)間(jian)(jian)安排。版(ban)面(mian)費不祥。該雜志近兩(liang)年未被列入(ru)預警名單(dan),建議您投(tou)(tou)稿(gao)。如您想了解更多投(tou)(tou)稿(gao)政策及投(tou)(tou)稿(gao)方案(an),請咨詢(xun)客服(fu)。
若用(yong)戶需(xu)要出(chu)版(ban)服(fu)務,請聯系出(chu)版(ban)商(shang)。